Summit Analytical is an internationally recognized leader in the area of biostatistics as applied to regulated human clinical studies required for FDA and other national drug and device approvals. Together, our team of experts have well over 100 years of experience in the collection, management and analysis of clinical data and have participated in an estimated number of clinical studies greater than 500 for both small and large multi-national biopharmaceutical companies. This experience embraces most of the top twelve pharmaceutical companies in the world as well as dozens of small to mid-sized biotechnology, nutriceutical, and medical device development companies. Established in 2001, Summit Analytical has an excellent track record of solving tough problems with innovative yet sound approaches.
In response to a growing critical need for eligible patients in global clinical trials Summit Analytical began developing an operational capability in Asia to facilitate patient recruitment several years ago. Currently we maintain a unique site management relationship with Selected Sites of Excellence (SSEs) in mainland China. We understand that clinical trial operations in China cannot be remotely managed effectively and have established embedded staff in key sites with access to hundreds of thousands of patients per year. Please visit out CRC China page to learn more about our innovative SMO model as well as our other China services